ロード中...
Efficacy of Abiraterone and Enzalutamide in Pre- and Postdocetaxel Castration-Resistant Prostate Cancer: A Trial-Level Meta-Analysis
We examined the comparative efficacies of first-line abiraterone and enzalutamide in pre- and postdocetaxel settings in castration-resistant prostate cancer (CRPC) through a trial level meta-analysis. A mixed method approach was applied to 19 unique studies containing 17 median overall survival (OS)...
保存先:
| 出版年: | Prostate Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5735648/ https://ncbi.nlm.nih.gov/pubmed/29359049 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8560827 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|